Company Filing History:
1 out of 832,912 Years Active: 2001
Title: Walter G. Schunack: Innovator in Histamine Receptor Research
Introduction
Walter G. Schunack is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that interact with histamine receptors. His work has implications for various therapeutic applications.
Latest Patents
Walter G. Schunack holds a patent for "Imidazole derivatives as histamine receptor H3 (ANT) agonists." This patent describes novel imidazole derivatives that function as histamine receptor H antagonists and/or agonists. The patent outlines the preparation of these compounds and their therapeutic uses. It also details chemical compounds that can act as histamine receptor H agonists, partial agonists, or antagonists, characterized by general formulas (Ia) or (Ib). The patent further discusses methods for revealing the agonist, partial agonist, or antagonist activity of such compounds in vivo.
Career Highlights
Throughout his career, Walter G. Schunack has focused on the development of innovative chemical compounds that target histamine receptors. His research has contributed to a better understanding of how these compounds can be utilized in drug development. He has been recognized for his expertise in this specialized area of pharmacology.
Collaborations
Walter G. Schunack has collaborated with esteemed colleagues such as Jean-Charles Schwartz and Jean-Michel Arrang. These collaborations have enhanced the depth and breadth of his research, leading to advancements in the field.
Conclusion
Walter G. Schunack is a prominent figure in the realm of histamine receptor research, with a patent that showcases his innovative contributions. His work continues to influence the development of new therapeutic agents.